Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Mar 11, 2014 · 10-K · 70 days after period end · 0001193125-14-093757
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$6.68M | -$4.10M | -$9.57M | — |
| EPS Diluted | -$0.45 | -$0.28 | -$0.98 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 11, 2014 · 70 d after period end
